An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Ribavirin Based Regimens in Patients With Chronic Hepatitis C With Previous Treatment Failure

NCT01798576 · clinicaltrials.gov ↗

TERMINATED

Status

282

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: Pegylated Interferon alfa-2a
DRUG: Ribavirin

Sponsor

Hoffmann-La Roche